Betters Medical Investment, one of the leading microwave ablation medical device developers and distributors in China for minimally invasive treatment of tumours, has postponed its HK$347m (US$44.2m) IPO following the more-than-40% collapse in its share price following pricing. The company had originally sold 248 million shares, which priced at the bottom HK$1.40 – HK$1.72 marketing range…
Home Healthcare Markets International Business Hong Kong: Betters Medical thinks better of proceeding with IPO